These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3756078)

  • 21. Resistance of V79 multicell spheroids to mitoxantrone: drug uptake and cytotoxicity.
    Bichay TJ; Inch WR
    Cancer Drug Deliv; 1987; 4(4):201-11. PubMed ID: 3454247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro cytotoxic drug sensitivity testing of human tumour xenografts grown as multicellular tumour spheroids.
    Jones AC; Stratford IJ; Wilson PA; Peckham MJ
    Br J Cancer; 1982 Dec; 46(6):870-9. PubMed ID: 6891260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytotoxicity of hypoxic cell sensitizers in multicell spheroids.
    Sutherland RM; Bareham BJ; Reich KA
    Cancer Clin Trials; 1980; 3(1):73-83. PubMed ID: 7389039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resistance of MGH-U1 bladder cancer spheroids to vincristine.
    Erlichman C; Wu A
    Anticancer Res; 1992; 12(4):1233-6. PubMed ID: 1503414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Combination chemotherapy of solid tumor--effects of hyaluronidase on doxorubicin (DXR) penetration into multicellular tumor spheroids (MTS)].
    Kohno N; Ichikawa G; Kawasaki K; Kawaida M; Ohnuma T
    Gan To Kagaku Ryoho; 1992 Jul; 19(7):981-6. PubMed ID: 1626955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Establishment of adriamycin-resistant human small-cell lung cancer cells in culture: analysis of the mechanism of resistance and cross-resistance].
    Kimura I; Ohnoshi T; Hiraki S; Miyamoto H
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):830-6. PubMed ID: 3032107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measurement of sensitivity to adriamycin in hybrid spheroids.
    Djordjevic B; Lange CS
    Cancer Invest; 1991; 9(5):505-12. PubMed ID: 1933483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of adriamycin-induced killing after delayed plating of plateau-phase V79-cells.
    Iliakis G; Nusse M; Egner J
    Br J Cancer; 1986 Aug; 54(2):245-9. PubMed ID: 3741761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitivities of monolayers and spheroids of the human bladder cancer cell line MGH-U1 to the drugs used for intravesical chemotherapy.
    Knuchel R; Hofstadter F; Jenkins WE; Masters JR
    Cancer Res; 1989 Mar; 49(6):1397-401. PubMed ID: 2493980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nitric oxide attenuates resistance to doxorubicin in three-dimensional aggregates of human breast carcinoma cells.
    Muir CP; Adams MA; Graham CH
    Breast Cancer Res Treat; 2006 Mar; 96(2):169-76. PubMed ID: 16331349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of cellular fatty acid alteration on adriamycin sensitivity in cultured L1210 murine leukemia cells.
    Guffy MM; North JA; Burns CP
    Cancer Res; 1984 May; 44(5):1863-6. PubMed ID: 6231987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytotoxicity of adriamycin to tumour cells in vivo and in vitro.
    Martin WM; McNally NJ
    Br J Cancer; 1980 Dec; 42(6):881-9. PubMed ID: 7459222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of an in vitro multicellular tumor spheroid model using microencapsulation and its application in anticancer drug screening and testing.
    Zhang X; Wang W; Yu W; Xie Y; Zhang X; Zhang Y; Ma X
    Biotechnol Prog; 2005; 21(4):1289-96. PubMed ID: 16080713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Superiority of adriamycin-14-octanoate over adriamycin in reducing viability of methotrexate-resistant L5178Y cells: brief communication.
    Hill BT; Price LA
    J Natl Cancer Inst; 1977 Oct; 59(4):1311-4. PubMed ID: 561857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the densities of clonogenic cells from EMT6 fibrosarcoma monolayer cultures, multicell spheroids, and solid tumors in ficoll density gradients.
    Ng CE; Inch WR
    J Natl Cancer Inst; 1978 May; 60(5):1017-22. PubMed ID: 642023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential cytotoxicity of [123I]IUdR, [125I]IUdR and [131I]IUdR to human glioma cells in monolayer or spheroid culture: effect of proliferative heterogeneity and radiation cross-fire.
    Neshasteh-Riz A; Mairs RJ; Angerson WJ; Stanton PD; Reeves JR; Rampling R; Owens J; Wheldon TE
    Br J Cancer; 1998; 77(3):385-90. PubMed ID: 9472632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of new N-alkyl analogues of adriamycin on in vitro survival and cell cycle progression of L1210 cells.
    Traganos F; Israel M; Silber R; Seshadri R; Kirschenbaum S; Potmesil M
    Cancer Res; 1985 Dec; 45(12 Pt 1):6273-9. PubMed ID: 4063977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formation, growth and morphology of multicellular tumor spheroids from a human colon carcinoma cell line (LoVo).
    Soranzo C; Della Torre G; Ingrosso A
    Tumori; 1986 Oct; 72(5):459-67. PubMed ID: 3798565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activity of 4'-(9-acridinylamino)methanesulfon-m-anisidide against Chinese hamster cells in multicellular spheroids.
    Wilson WR; Whitmore GF; Hill RP
    Cancer Res; 1981 Jul; 41(7):2817-22. PubMed ID: 7018670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of adriamycin on the cell cycle traverse of a human lymphoid cell line.
    Barlogie B; Drewinko B; Johnston DA; Freireich EJ
    Cancer Res; 1976 Jun; 36(6):1975-9. PubMed ID: 1268851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.